Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Oncternal Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 24 | 26 | +2 |
| Shares | 450.0K | 483.1K | +33.1K (+7.4%) |
| Value | $4.05M | $3.67M | −$378.7K (−9.4%) |
New holders (4)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pasadena Private Wealth, LLC | 25,000 | $190.0K | 0.04% |
| US Bancorp | 100 | $760 | 0.00% |
| FMR LLC | 72 | $547 | 0.00% |
| Bank of America Corp | 22 | $167 | 0.00% |
Sold out (2)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| ADAR1 Capital Management, LLC | 2,472 | $22.2K |
| Truvestments Capital LLC | 22 | $198 |